Stockscreener 앱 받기
17.11
0.33%
-0.0572
전일 마감가:
$17.16
열려 있는:
$17.35
하루 거래량:
4,367
Relative Volume:
0.45
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+4.17%
1개월 성능:
+21.14%
6개월 성능:
+36.85%
1년 성능:
+56.93%
1일 변동 폭
$16.94
$17.41
1주일 범위
$16.19
$17.41
52주 변동 폭
$7.14
$17.41
Advisorshares Psychedelics Etf Stock (PSIL) Company Profile
PSIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PSIL
Advisorshares Psychedelics Etf
|
17.11 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
313.05 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
635.99 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
639.12 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
245.14 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
566.42 | 124.43B | 0 | 0 | 0 | 0.00 |
Advisorshares Psychedelics Etf 주식(PSIL)의 최신 뉴스
(PSIL) Proactive Strategies - news.stocktradersdaily.com
Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money
(PSIL) Investment Analysis - news.stocktradersdaily.com
5 ETFs That Beat the Market in the First Half of 2025 - Zacks Investment Research
(PSIL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors - Benzinga
Worst Thematic ETFs of 2021: How are they faring today? - Trackinsight
(PSIL) Trading Report - news.stocktradersdaily.com
Where are the Opportunities in (PSIL) - news.stocktradersdaily.com
The Zacks Analyst Blog Highlights SGDM, SLVP, SHLD, COPJ and PSIL - Zacks Investment Research
5 Sector ETFs That Have Outperformed the S&P 500 in Q1 - TradingView
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading Down 0.2% – What’s Next? - Defense World
(PSIL) Investment Analysis and Advice - news.stocktradersdaily.com
Best Mushroom Stocks: Top Picks, Pros and Cons - timothysykes.com
Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF - ACCESS Newswire
TheStreet Pro - TheStreet
5 Best-Performing Sector ETFs Halfway Through Q1 - MSN
Psychedelic Funding, Public Markets, and M&A in 2024 - Psychedelic Alpha
When the Price of (PSIL) Talks, People Listen - Stock Traders Daily
Psychedelic ETF PSIL Is 2025's Best-Performing ETF - etf.com
5 ETFs That Beat Market Turmoil With Gains Last Week - Benzinga
5 Best-Performing Sector ETFs of Volatile January - MSN
High-Momentum ETFs Leading the Market This Year - MarketBeat
Shares Soar as GH Research Unveils Promising Drug Trial - Value The Markets
5 Best-Performing ETFs of January - Yahoo Finance
Under-The-Radar Opportunities In ETFs - Seeking Alpha
Under-the-Radar Opportunities in ETFs - ETF Trends
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Price Down 1.2% – What’s Next? - Defense World
(PSIL) Trading Advice - Stock Traders Daily
Objective long/short (PSIL) Report - Stock Traders Daily
5 Best-Performing Sector ETFs of Q4 - Nasdaq
(PSIL) Technical Data - Stock Traders Daily
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading Down 0.8% – Time to Sell? - Defense World
Why Is Penny Stock Clearmind Gaining Today? - Benzinga
EMIF, PSIL: 2 ETFs with Over 20% Upside Potential, According to Analysts - TipRanks
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination - Barchart.com
No Trippin’: Trump Trade Pushes PSIL, VCAR Higher - Yahoo Finance
5 Best-Performing ETFs of October - Yahoo Finance
DRUG Enhances Buzz for Psilocybin, Psychedelic ETFs - ETF.com
Reverse split for AdvisorShares Psychedelic ETF starts today - Crain's Chicago Business
ADVISORSHARES PSYCHEDELICS ETF To Carry Out 1-for-10 Reverse Stock Split On September 10th, 2024 - 富途牛牛
AdvisorShares Announces Reverse Split of ETF - Stock Titan
Best Psychedelic ETFs - Benzinga
Losing Ones Sense of Self – How Psilocybin Breakthroughs Could Spark Fresh Investments - Securities.io
Top and Flop ETFs of the First Half - Nasdaq
Best and Worst ETF Zones of Q2 - Nasdaq
LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance’ - Bloomberg
Psychedelic Funding & Public Markets in 2023 - Psychedelic Alpha
Psychedelics Are Going Mainstream. Investing in Them Hasn’t. - WSJ
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More - Benzinga
How to Invest in Psychedelics - Investing News Network
Advisorshares Psychedelics Etf (PSIL) 재무 분석
Advisorshares Psychedelics Etf (PSIL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.06%
0.80%
자본화:
|
볼륨(24시간):